Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-169087
Filing Date
2023-06-16
Accepted
2023-06-16 16:53:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 S-3 d519225ds3.htm S-3 149620
2 EX-5.1 d519225dex51.htm EX-5.1 14807
3 EX-23.1 d519225dex231.htm EX-23.1 1654
4 EX-FILING FEES d519225dexfilingfees.htm EX-FILING FEES 18390
5 GRAPHIC g519225g04s40.jpg GRAPHIC 43627
6 GRAPHIC g519225g0616112332819.jpg GRAPHIC 1691
7 GRAPHIC g519225log.jpg GRAPHIC 4254
  Complete submission text file 0001193125-23-169087.txt   254280
Mailing Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075
Business Address 142 NORTH CEDROS AVENUE, SUITE B SOLANA BEACH CA 92075 (858) 925-8215
eFFECTOR Therapeutics, Inc. (Filer) CIK: 0001828522 (see all company filings)

IRS No.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-272738 | Film No.: 231022019
SIC: 2834 Pharmaceutical Preparations